Work

Is Cholesteryl Ester Transfer Protein Inhibition an Effective Strategy to Reduce Cardiovascular Risk?

Year: 2015

Type: article

Source: Circulation

DOI: 10.1161/circulationaha.115.014026

Authors: G. Kees Hovingh, Kausik K. Ray, S. Matthijs Boekholdt

Institutions: Amsterdam UMC Location University of Amsterdam, Imperial College London

Language: English

Topic: Lipoproteins and Cardiovascular Health

Subfield: Cardiology and Cardiovascular Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: green

Funders: Amgen, Bristol-Myers Squibb, Eli Lilly and Company, Pfizer, Sanofi, Regeneron Pharmaceuticals, Kowa Company, Novo Nordisk

OpenAlex ID: W1856265350

FWCI: 5.22

Cites: 52

Cited by: 31

Related to: 10